Benchmark Holdings, a global aquaculture genetics, health and specialist nutrition firm, saw its revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) surge in the first quarter of 2022, with strong performances across all divisions.
Group revenue in the period increased 38 percent to £40 million (€48 million/$54.3 million), while adjusted EBITDA more than doubled to £7.4 million (€8.9 million/$10.1 million).
The group also said it narrowed its operating loss to £1.5
